Overexpression of the peroxisome proliferator activated receptor α or the human c-Ha-ras transgene is not involved in tumorigenesis induced by di(2-ethylhexyl)phthalate in rasH2 mice

Cancer Letters

Volumn 192, Issue 2, 2003, Pages 199-203

  Toyosawa, Kaoru ^a   Okugawa, Kenji ^a   Teranishi, Yasuhiro ^a   Tanaka, Kohji ^a   Matsuoka, Nobuo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Di(2 ethylhexyl)phthalate; Human c Ha ras; Peroxisome proliferator activated receptor ; RasH2 mice

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL; MALE; MOUSE; NONHUMAN; ONCOGENE C H RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0037474702     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00714-0     Document Type: Article

References (19)

1. Grasso P. Hepatic changes associated with peroxisome proliferation. Gibson G., Lake B. Peroxisomes: Biology and Importance in Toxicology and Medicine. 1993;639-652 Taylor and Francis Ltd, London.
2. Huber W.W., Grasl-Kraupp B., Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26:1996;365-481.
3. Kluwe W.M., Haseman J.K., Douglas J.F., Huff J.E. The carcinogenicity of dietary di(2-ethylhexyl)phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J. Toxicol. Environ. Health. 10:1982;797-815.
4. Ward J.M., Diwan B.A., Ohshima M., Hu H., Schuller H.M., Rice J.M. Tumor-initiating and promoting activities of di(2-ethylhexyl)phthalate in vivo and in vitro. Environ. Health Perspect. 65:1986;279-291.
5. Corton J.C., Lapinskas P.J., Gonzalez F.J. Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448:2000;139-151.
6. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene. 5:1990;1195-1200.
7. Ando K., Saitoh A., Hino O., Takahashi R., Kimura M., Katsuki M. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes. Cancer Res. 52:1992;978-982.
8. Mitsumori K., Wakana S., Yamamoto S., Kodama Y., Yasuhara K., Nomura T., Hayashi Y., Maronpot R.R. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mol. Carcinog. 20:1997;298-307.
9. Hayashi S., Mori I., Nonoyama T., Mitsumori K. Point mutations of the c-Ha-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-Ha-ras gene. Toxicol. Pathol. 26:1998;556-561.
10. Mori I., Yasuhara K., Hayashi S., Nonoyama T., Nomura T., Mitsumori K. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene. Cancer Lett. 153:2000;199-209.
11. Mori I., Hayashi S., Nonoyama T., Yasuhara K., Mitsumori K., Masegi T. Point mutations of the c-Ha-ras gene in spontaneous pulmonary tumors of transgenic mice carrying the human c-Ha-ras gene. J. Toxicol. Pathol. 13:2000;165-172.
12. Toyosawa K., Okimoto K., Kobayashi I., Kijima K., Kikawa E., Kohchi M., Koujitani T., Tanaka K., Matsuoka N. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toxicol. Pathol. 29:2001;458-466.
13. Maruyama C., Tomisawa M., Wakana S., Yamazaki H., Kijima H., Suemizu H., Ohnishi Y., Urano K., Hioki K., Usui T., Nakamura M., Tsuchida T., Mitsumori K., Nomura T., Tamaoki N., Ueyama Y. Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol. Rep. 8:2001;233-237.
14. Alden C., Smith P., Morton D. Application of genetically altered models as replacement for the lifetime mouse bioassay in pharmaceutical development. Toxicol. Pathol. 30:2002;135-138.
15. Morton D., Alden C.L., Roth A.J., Usui T. The Tg rasH2 mouse in cancer hazard identification. Toxicol. Pathol. 30:2002;139-146.
16. Pitot H.C., Beer D.G., Hendrich S. Multistage carcinogenesis of the rat hepatocyte. Butterworth B.E., Slaga T.J. Banbury Report 25: Nongenotoxic Mechanisms in Carcinogenesis. 1987;41-53 Cold Spring Harbor Laboratory, New York.
17. Sai-Kato K., Takagi A., Umemura T., Hasegawa R., Kurokawa Y. Role of oxidative stress in non-genotoxic carcinogenesis with special reference to liver tumors induced by peroxisome proliferators. Biomed. Environ. Sci. 8:1995;269-279.
18. Smith-Oliver T., Butterworth B.E. Correlation of the carcinogenic potential of di(2-ethylhexyl)phthalate (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutat. Res. 188:1987;21-28.
19. James N.H., Gill J.H., Brindle R., Woodyatt N.J., Macdonald N., Rolfe M., Hasmall S.C., Tugwood J.D., Holden P.R., Roberts R.A. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis. Toxicol. Lett. 102-103:1998;91-96.